Scoreboard / ISRG
Intuitive Surgical ISRG
Setup Snapshot
The Setup in One Card
How ISRG scored, how it moved against the market, and the catalyst behind the move. A high score means the stock deserves research time, not that it is a buy.
Friday Five Score
Weekly Rank
05 of 5
Sector Trend
Improving-0.22%
Actionability
Avoid for Now
Catalyst
Guidance DisappointmentBeat on sales and profit but its procedure growth outlook disappointed
Returns are measured from the Thursday, July 16 close to the Thursday, July 23 close. Benchmarks: S&P 500 -1.7% and Nasdaq Composite -2.9% for the week. Benchmark figures are official index closes; sector figures use SPDR sector ETF closes because the official S&P sector index closes for this window were not yet published at press time.
Why It Moved
The Story Behind the Move
Catalyst
After the close on July 16, Intuitive Surgical beat on both revenue and earnings, but its 2026 forecast for how fast robotic surgery procedures will grow, about 13.5 to 15.5%, disappointed investors and analysts cut price targets.
Why It Mattered
For a stock priced for perfection, a merely good growth outlook is a disappointment, and the market repriced it lower even though the quarter beat.
Risk Note
The core issue is valuation and expectations, the business itself is financially strong, so the move was a reset of what investors were willing to pay, not a broken company.
Reader Takeaway
For an expensive, high expectations stock, the forward guidance can matter far more than beating the quarter.
This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.